RGS1 expression is associated with poor prognosis in multiple myeloma

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Pathology

• Publication date

  2016-07-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jclinpath-2016-203713PMID 27445341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulator of G Protein Signaling 1 Suppresses CXCL12-Mediated Migration and AKT Activation in RPMI 8226 Human Plasmacytoma Cells and Plasmablasts

  2015cited by this paper
• International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

  2014cited by this paper
• IMWG consensus on risk stratification in multiple myeloma

  2014cited by this paper
• P values and statistical practice.

  2013cited by this paper
• Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer

  2013cited by this paper
• RGS expression in cancer: oncomining the cancer microarray data

  2013cited by this paper
• Multiple myeloma: 2013 update on diagnosis, risk‐stratification, and management

  2013cited by this paper
• Update on risk stratification and treatment of newly diagnosed multiple myeloma

  2011cited by this paper
• Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

  2011cited by this paper
• Genetic Variations in the Regulator of G-Protein Signaling Genes Are Associated with Survival in Late-Stage Non-Small Cell Lung Cancer

  2011cited by this paper
• RNA Vaccines in Cancer Treatment

  2010cited by this paper
• International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

  2009cited by this paper
• Regulator of G-protein signaling (RGS) proteins in cancer biology.

  2009cited by this paper
• Novel Role for RGS1 in Melanoma Progression

  2008cited by this paper
• Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells

  2008cited by this paper
• G-protein-coupled receptors and cancer

  2007cited by this paper
• Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling

  2007cited by this paper
• WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2007cited by this paper
• CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia

  2006cited by this paper
• Molecular pathogenesis and a consequent classification of multiple myeloma.

  2005cited by this paper
• Expression of regulator of G protein signalling proteins in natural killer cells, and their modulation by Ly49A and Ly49D

  2005cited by this paper
• Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia

  2005cited by this paper
• Differential expression of regulator of G‐protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells

  2005cited by this paper
• Distinct sets of genetic alterations in melanoma.

  2005cited by this paper
• Abnormal B-Cell Responses to Chemokines, Disturbed Plasma Cell Localization, and Distorted Immune Tissue Architecture in Rgs1−/− Mice

  2004cited by this paper
• Toll-Like Receptor Signaling Alters the Expression of Regulator of G Protein Signaling Proteins in Dendritic Cells: Implications for G Protein-Coupled Receptor Signaling

  2004cited by this paper
• Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.

  2003cited by this paper
• Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells.

  2003cited by this paper
• A molecular compendium of genes expressed in multiple myeloma.

  2002cited by this paper
• Molecular cytogenetic characterization of non‐Hodgkin lymphoma cell lines

  2002cited by this paper
• Regulator of G protein signaling proteins: novel multifunctional drug targets.

  2001cited by this paper
• Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization.

  2001cited by this paper
• Comparative genomic hybridization analysis of nasopharygeal carcinoma: consistent patterns of genetic aberrations and clinicopathological correlations.

  2001cited by this paper
• Regulator of G Protein Signaling 1 (RGS1) Markedly Impairs Giα Signaling Responses of B Lymphocytes

  2000cited by this paper
• Cytoplasmic, Nuclear, and Golgi Localization of RGS Proteins

  2000cited by this paper
• Identification of a novel amplicon at 1q31 in pancreatic cancer cell lines.

  1999cited by this paper
• RGS9, a GTPase accelerator for phototransduction.

  1998cited by this paper
• Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

  1996cited by this paper

• Regulators of G protein Signaling (RGS) proteins in GtoPdb v.2025.3

  2025cites this paper
• Targeting CREB1/p300-mediated RGS1 expression in tumor-associated macrophages improves the efficacy of anti-PD-1 therapy in triple-negative breast cancer.

  2025cites this paper
• Liposomes-loaded miR-128-3p exert neuroprotective effects in hypoxia-ischemia injury by targeting Rgs1 in neonatal mice.

  2025cites this paper
• RGS1 is an effective T-cell marker of acute myeloid leukemia remission after hematopoietic stem cell transplantation.

  2025cites this paper
• Phylogenetic tree inference from single-cell RNA sequencing data

  2025cites this paper
• An inflammatory response-related gene signature can predict the prognosis and impact the immune infiltration of multiple myeloma

  2024cites this paper
• Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma

  2024influential citation
• Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next?

  2024cites this paper
• Regulator of G protein signaling 1 is a potential target in gastric cancer and impacts tumor‐associated macrophages

  2024cites this paper
• Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers

  2023cites this paper
• Prognostic value of RGS1 and mTOR Immunohistochemical expression in Egyptian multiple myeloma patients; A single center study

  2023influential citation
• RGS proteins and their roles in cancer: friend or foe?

  2023cites this paper
• LncRNA FEZF1‐AS1 accelerates multiple myeloma progression by regulating IGF2BP1/BZW2 signaling

  2023cites this paper
• Tumor-intrinsic RGS1 potentiates checkpoint blockade response via ATF3-IFNGR1 axis

  2023cites this paper
• Function and regulation of RGS family members in solid tumours: a comprehensive review

  2023cites this paper
• ScRNA-seq revealed targeting regulator of G protein signaling 1 to mediate regulatory T cells in Hepatocellular carcinoma

  2023cites this paper
• Identification of DNA methylation-regulated differentially expressed genes in RA by integrated analysis of DNA methylation and RNA-Seq data

  2022cites this paper
• RGS1 serves as an antitumor target to inhibit proliferation of NICN87-DR cells and tumor growth in the gastric cancer mouse model

  2022cites this paper
• Functions of regulators of G protein signaling 16 in immunity, inflammation, and other diseases

  2022cites this paper
• Elevated expression of sepiapterin reductase, regulator of G protein signaling 1, hypothetical protein CXorf58 homolog, and zinc finger and BTB domain–containing protein 21 isoform X2 is associated with progression of hepatocellular carcinoma

  2021cites this paper
• NDT_A_300773 1165..1181

  2021cites this paper
• Single-Cell Transcriptome Analysis Reveals RGS1 as a New Marker and Promoting Factor for T-Cell Exhaustion in Multiple Cancers

  2021cites this paper
• Regulators of G protein Signaling (RGS) proteins in GtoPdb v.2021.2

  2021cites this paper
• Biliverdin Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating the miR-27a-3p/Rgs1 Axis

  2021cites this paper
• PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma

  2020cites this paper
• Integrative analyses of single-cell transcriptome and regulome using MAESTRO

  2020cites this paper
• Abnormal PTBP1 Expression Sustains the Disease Progression of Multiple Myeloma

  2020cites this paper
• OSskcm: an online survival analysis webserver for skin cutaneous melanoma based on 1085 transcriptomic profiles

  2020cites this paper
• Single-Cell Sequencing Reveals the Relationship between Phenotypes and Genotypes of Klinefelter Syndrome

  2019cites this paper
• A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes.

  2019cites this paper
• Regulators of G protein signaling in cardiovascular function during pregnancy.

  2018cites this paper
• Emerging Roles of Regulators of G Protein Signaling (RGS) Proteins in the Immune System.

  2017cites this paper
• Towards Stratified Medicine in Plasma Cell Myeloma

  2016cites this paper
• Prognostic significance of the red blood cell distribution width that maintain at high level following completion of first line therapy in mutiple myeloma patients

  2015cites this paper